S. Lubin

发表

Lack of a Pharmacokinetic Interaction Between Saxagliptin and Dapagliflozin in Healthy Subjects: A Randomized Crossover Study.

F. LaCreta, D. Boulton, B. Vakkalagadda, 2016, Clinical therapeutics.

Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator

Sean Zhang, Daphne D Williams, E. Masson, 2016, British journal of clinical pharmacology.

Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.

S. Griffen, F. LaCreta, D. Boulton, 2015, Clinical therapeutics.

Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants

A. Bello, Liping Zhang, Zhaoqing Wang, 2022, Clinical Pharmacokinetics.

Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa Inhibitor

D. Seiffert, Zhaoqing Wang, V. Perera, 2022, Cardiology and Therapy.

Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa Inhibitor

D. Seiffert, Zhaoqing Wang, V. Perera, 2022, Cardiology and Therapy.

Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment

A. Bello, Liping Zhang, Zhaoqing Wang, 2022, Clinical Pharmacokinetics.

Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participants

D. Seiffert, Zhaoqing Wang, T. Ueno, 2022, Scientific Reports.

Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid‐dependent, human immunodeficiency virus seronegative participants

Ming Chang, C. Llamoso, M. Magee, 2019, British journal of clinical pharmacology.

Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants

N. Thakkar, B. Vakkalagadda, C. Llamoso, 2022, Antimicrobial agents and chemotherapy.

Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.

S. Griffen, F. LaCreta, D. Boulton, 2016, Clinical therapeutics.

Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor

D. Seiffert, Zhaoqing Wang, V. Perera, 2022, Scientific reports.

Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid‐dependent, human immunodeficiency virus seronegative participants

Ming Chang, C. Llamoso, M. Magee, 2019, British journal of clinical pharmacology.

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants

Zhaoqing Wang, V. Perera, S. Lubin, 2024, Scientific reports.